Medicare's New GLP-1 Discount Program Has Limitations, Excluding Some Patients with Medical Needs

A new pilot program by Medicare offering discounted coverage for three GLP-1 medications for weight loss and management has a significant catch: the $50 price applies only to patients using the drug solely for weight loss, potentially excluding those with greater medical needs who face higher monthly costs. The program, launched in July, aims to assess if covering these drugs could lead to future Medicare savings.